EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Emerging role of small RNAs in inflammatory bowel disease and associated colorectal cancer (Review)

Wei Qiu, Francis Atim Akanyibah, Yuxuan Xia, Dickson Kofi Wiredu Ocansey, Fei Mao, Yuelan Liang

International Journal of Molecular Medicine · 18.12.2024 · 55 (2)

DOI: 10.3892/ijmm.2024.5474 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, online erschienen am 18.12.2024. Verfasst von Wei Qiu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Nanjing Drum Tower Hospital Group Suqian Hospital, Suqian, Jiangsu 223800, P.R. China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Inflammatory Bowel Diseases, MicroRNAs. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 325 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel diseases (IBDs), which encompasses Crohn's disease and ulcerative colitis, is a chronic inflammatory condition associated with an increased risk of colorectal cancer (CRC). Small RNAs have been linked to various illnesses, including IBD and CRC. These small RNAs also serve as potential biomarkers for these diseases, offering a cutting‑edge approach to investigating possible treatments. To date, treatments involving oral nucleic acid usage are still unachievable due to the instability of medications in the gastrointestinal tract (GIT), their lack of ability to effectively target disease tissues and their notable adverse effects. However, nanoparticle or exosome delivery systems of nucleic acid medications effectively target disease tissues by overcoming the instability of the GIT, resulting in an effective outcome. In the present review, the biogenesis of small RNAs (tRNA‑derived small RNA, microRNA, small nucleolar RNA and p‑element‑induced wimpy testis‑interacting RNA), their roles in the pathogenesis of IBD and CRC as well as their application as possible diagnostic and prognostic biomarkers in IBD and CRC are discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsInflammatory Bowel DiseasesMicroRNAsHumansAnimals

Stichwörter der Autor:innen

colorectal cancerdiagnosisinflammatory bowel diseaseprognosissmall RNAtherapy

Substanzen

MicroRNAs

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Nanjing Drum Tower Hospital Group Suqian Hospital, Suqian, Jiangsu 223800, P.R. China.
  • Key Laboratory of Medical Science and Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013, P.R. China.
  • Department of Laboratory Medicine, Suzhou Wuzhong People's Hospital, Suzhou, Jiangsu 215128, P.R. China.

Zitieren

APA

Qiu, W., Akanyibah, F. A., Xia, Y., Ocansey, D. K. W., Mao, F., & Liang, Y. (2024). Emerging role of small RNAs in inflammatory bowel disease and associated colorectal cancer (Review). International Journal of Molecular Medicine, 55(2). https://doi.org/10.3892/ijmm.2024.5474

Vancouver

Qiu W, Akanyibah FA, Xia Y, Ocansey DKW, Mao F, Liang Y. Emerging role of small RNAs in inflammatory bowel disease and associated colorectal cancer (Review). International Journal of Molecular Medicine. 2024;55(2). doi:10.3892/ijmm.2024.5474

BibTeX
@article{Qiu2024,
  author = {Qiu, Wei and Akanyibah, Francis Atim and Xia, Yuxuan and Ocansey, Dickson Kofi Wiredu and Mao, Fei and Liang, Yuelan},
  title = {Emerging role of small RNAs in inflammatory bowel disease and associated colorectal cancer (Review)},
  journal = {International Journal of Molecular Medicine},
  year = {2024},
  volume = {55},
  number = {2},
  doi = {10.3892/ijmm.2024.5474}
}
Kostenlos starten →